Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467597 · ClinicalTrials.gov registry record
Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 36
- Enrollment target
NCT00467597: Completed study, sponsored by US Department of Veterans Affairs.
NCT00467597 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00467597 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The ultimate goal of this proposal is to reduce dyskinesia in Parkinson's Disease (PD) patients. Dyskinesias are abnormal movements, often caused by the standard treatment for PD symptoms, levodopa. In this study, we will test if biochemical devices are equal to the clinical rating system in measuring dyskinesias.
Primary Outcome
Gaitmat stance measurements were measured every half hour throughout an 8 hour period. Area under the curve was computed using the trapezoidal method for root mean squared velocity in the anterior-posterior direction. Each subject's unique baseline was used by computing the mean of the test-retest period measured at 08:00 am.
Interventions
- DRUG Levodopa (delivered intravenously)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2006-04 |
| Est. Completion | 2013-10 |
What the finished NCT00467597 record still lists
NCT00467597 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Levodopa (delivered intravenously) is the first listed.
NCT00467597 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00467597 about?
NCT00467597 is a clinical study titled "Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)". The ultimate goal of this proposal is to reduce dyskinesia in Parkinson's Disease (PD) patients. Dyskinesias are abnormal movements, often caused by the standard treatment for PD symptoms, levodopa. In this study, we will test if biochemical devices are equal to the clinical rating system in measuri...
What is the current status of trial NCT00467597?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2006-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT00467597?
The interventions under investigation include: Levodopa (delivered intravenously) (DRUG).
Who is sponsoring clinical trial NCT00467597?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia